Patent ID: 7109234

Claim:
A 3-arylthiopropylamino-3,4-dihydro-2H-1,5-aryloxathiepine derivative of general formula (1) wherein: R 1 and R 2 , which are identical or different, represent: a hydrogen atom; a fluorine atom or a chlorine atom; a hydroxyl group; a linear or branched (C 1 –C 3 ) alkyl; a cyclopropyl radical; a cyclopropoxy radical; R 3 represents: a linear or branched (C 1 –C 3 ) alkyl radical; a hydroxyl group or a methoxy radical; R 4 represents: a hydrogen atom or a methyl radical; and R 5 and R 6 , which are identical or different, represent: a hydrogen atom; a linear or branched (C 1 –C 3 ) alkyl radical; a linear or branched (C 1 –C 3 ) alkoxy radical; a linear or branched (C 1 –C 3 ) alkylthio radical; an alkylamino radical; provided that, when R 4 represents a methyl radical, then R 5 represents a hydrogen atom, a (C 1 –C 3 ) alkoxy radical, a linear or branched (C 1 –C 3 ) alkylthio radical or an alkylamino radical, its addition salts and the hydrates of these addition salts with pharmaceutically acceptable inorganic acids or pharmaceutically acceptable organic acids, and its tautomeric forms, the enantiomers and the mixtures of enantiomers, and the stereoisomers, pure or as a racemic or nonracemic mixture.